BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 17890822)

  • 1. Comparative evaluation of smear cytology & hybrid capture II for the diagnosis of cervical cancer.
    Kumar K; Iyer VK; Bhatla N; Kriplani A; Verma K
    Indian J Med Res; 2007 Jul; 126(1):39-44. PubMed ID: 17890822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
    Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
    Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy compared with human papilloma virus testing (Hybrid Capture II) and conventional cervical cytology as a primary screening test for cervical high-grade lesions and cancer in 1555 patients with biopsy confirmation.
    Guillaud M; Benedet JL; Cantor SB; Staerkel G; Follen M; MacAulay C
    Cancer; 2006 Jul; 107(2):309-18. PubMed ID: 16773634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
    Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV testing: where are we now?
    Bovicelli A; Bristow RE; Montz FJ
    Anticancer Res; 2000; 20(6C):4673-80. PubMed ID: 11205199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum.
    Lukic A; Canzio C; Patella A; Giovagnoli M; Cipriani P; Frega A; Moscarini M
    Anticancer Res; 2006; 26(6C):4843-9. PubMed ID: 17214350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hospital-based study on the use of paramedical personnel for clinical downstaging of cancer cervix.
    Bhargava VL; Verma K; Sharma R; Batra S; Anandalakshmy PN
    Indian J Med Res; 1993 Apr; 98():65-8. PubMed ID: 8344733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Integrated colposcopy and phase contrast microscopy for diagnosis of squamous intraepithelial lesions and invasive cervical neoplasms].
    Głab G; Basta A; Strama M; Kolawa W
    Przegl Lek; 1999; 56(1):30-6. PubMed ID: 10375922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biospectroscopy insights into the multi-stage process of cervical cancer development: probing for spectral biomarkers in cytology to distinguish grades.
    Purandare NC; Patel II; Trevisan J; Bolger N; Kelehan R; von Bünau G; Martin-Hirsch PL; Prendiville WJ; Martin FL
    Analyst; 2013 Jul; 138(14):3909-16. PubMed ID: 23338619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray detection of human papilloma virus genotypes among Turkish women with abnormal cytology at a colposcopy unit.
    Cilingir IU; Bengisu E; Ağaçfidan A; Koksal MO; Topuz S; Berkman S; Iyibozkurt AC
    J Turk Ger Gynecol Assoc; 2013; 14(1):23-7. PubMed ID: 24592066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geometrical nuclear diagnosis and total paths of cervical cell evolution from normality to cancer.
    Velásquez JO; Bohórquez SE; Herrera SC; Cajeli DD; Velásquez DM; de Alonso MM
    J Cancer Res Ther; 2015; 11(1):98-104. PubMed ID: 25879345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of cervical smear and pathohistological findings.
    Asotic A; Taric S; Asotic J
    Med Arch; 2014; 68(2):106-9. PubMed ID: 24937933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can screening for cervical cancer be improved, especially in developing countries?
    Miller AB; Sankaranarayanan R; Bosch FX; Sepulveda C
    Int J Cancer; 2003 Nov; 107(3):337-40. PubMed ID: 14506730
    [No Abstract]   [Full Text] [Related]  

  • 17. American Society of Cytopathology statement on new technologies in cervical cytology screening. June 2000.
    Anal Quant Cytol Histol; 2000 Aug; 22(4):351. PubMed ID: 10965413
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of crush smear cytology in the diagnosis of gastrointestinal malignancy.
    Saha M; Hossain A; Bhuiyan SH; Islam MN; Chowdhury MS; Kumar SU
    Mymensingh Med J; 2014 Jul; 23(3):496-502. PubMed ID: 25178602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of patients with inflammatory smear results in general practice.
    Bates CM
    Genitourin Med; 1993 Apr; 69(2):126-9. PubMed ID: 8509093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brush cytology for the diagnosis of rectal carcinoma.
    Farouk R; Edwards J; Thorne M; Young W; MacDonald AW; Monson JR; Lee PW
    Br J Surg; 1996 Oct; 83(10):1456-8. PubMed ID: 8944471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.